Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R King

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Journal of the American Medical Informatics Association : JAMIA|July 31, 2024
Effect of standardized EHR-integrated handoff report on intraoperative communication outcomesJoanna Abraham, Christopher R King, Lavanya Pedamallu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancerChristopher R King, James D Brooks, Harcharan Gill, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2009
Incidental testicular irradiation from prostate IMRT: it all adds upChristopher R King, Peter G Maxim, Annie Hsu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patientsChristopher R King, John E McNeal, Harcharan Gill, et al.
European Urology Oncology|June 4, 2019
First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer PathologyJung Julie Kang, Robert E Reiter, Michael L Steinberg, et al.
The Journal of Urology|December 3, 2014
Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapyJung Julie Kang, Robert E Reiter, Michael L Steinberg, et al.
Cancer|December 21, 2016
Urinary toxicity after stereotactic body radiotherapy: The boy who cried wolf?Amar U Kishan, Patrick A Kupelian, Michael L Steinberg, et al.
Research Square|December 11, 2023
Social Vulnerability and Surgery Outcomes: A Cross-sectional AnalysisMohamed Abdelhack, Sandhya Tripathi, Yixin Chen, et al.
European Urology|January 24, 2017
Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73Amar U Kishan, Michael L Steinberg, Patrick A Kupelian, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
In Regard to Bauman et alAmar U Kishan, Michael L Steinberg, Patrick A Kupelian, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Journal of the American Medical Informatics Association : JAMIA|July 31, 2024
Effect of standardized EHR-integrated handoff report on intraoperative communication outcomesJoanna Abraham, Christopher R King, Lavanya Pedamallu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancerChristopher R King, James D Brooks, Harcharan Gill, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2009
Incidental testicular irradiation from prostate IMRT: it all adds upChristopher R King, Peter G Maxim, Annie Hsu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patientsChristopher R King, John E McNeal, Harcharan Gill, et al.
European Urology Oncology|June 4, 2019
First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer PathologyJung Julie Kang, Robert E Reiter, Michael L Steinberg, et al.
The Journal of Urology|December 3, 2014
Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapyJung Julie Kang, Robert E Reiter, Michael L Steinberg, et al.
Cancer|December 21, 2016
Urinary toxicity after stereotactic body radiotherapy: The boy who cried wolf?Amar U Kishan, Patrick A Kupelian, Michael L Steinberg, et al.
Research Square|December 11, 2023
Social Vulnerability and Surgery Outcomes: A Cross-sectional AnalysisMohamed Abdelhack, Sandhya Tripathi, Yixin Chen, et al.
European Urology|January 24, 2017
Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73Amar U Kishan, Michael L Steinberg, Patrick A Kupelian, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
In Regard to Bauman et alAmar U Kishan, Michael L Steinberg, Patrick A Kupelian, et al.
Pageof 12